BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15772984)

  • 1. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
    Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
    J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses.
    Brighenti A; Andrulis M; Geissinger E; Roth S; Müller-Hermelink HK; Rüdiger T
    Histopathology; 2005 Jul; 47(1):90-100. PubMed ID: 15982328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
    Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
    Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
    Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
    J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
    White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
    J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
    Carbone A; Gloghini A; Gaidano G
    Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
    King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
    Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype.
    Usui T; Wakatsuki Y; Matsunaga Y; Kaneko S; Koseki H; Kita T
    J Immunol; 1997 Apr; 158(7):3197-204. PubMed ID: 9120274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
    Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
    Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.
    Bai M; Panoulas V; Papoudou-Bai A; Horianopoulos N; Kitsoulis P; Stefanaki K; Rontogianni D; Agnantis NJ; Kanavaros P
    Leuk Lymphoma; 2006 Mar; 47(3):495-501. PubMed ID: 16396774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.
    Adams H; Liebisch P; Schmid P; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):96-101. PubMed ID: 18838917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
    Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J
    Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
    Torlakovic E; Torlakovic G; Nguyen PL; Brunning RD; Delabie J
    Am J Surg Pathol; 2002 Oct; 26(10):1343-50. PubMed ID: 12360049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
    Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
    Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.